Alnylam Pharmaceuticals, Inc. (ALNY)

395.89 +3.79 (+0.97%) USD  |  NASDAQ  |  Dec 18, 16:00
395.89 0.00 (0.00%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly)

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
BridgeBio Pharma, Inc. Upgrade
Amgen, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade